发明名称 |
anticorpo biespecífico, composição farmacêutica, uso, método de tratamento de um paciente que sofre de câncer e de um paciente que sofre de inflamação |
摘要 |
The current invention relates to bispecific antibodies wherein the binding affinity to one of the two antigens is reduced and which can be activated by tumor- or inflammation-specific proteases, and the preparation and use of such bispecific antibodies. |
申请公布号 |
BR112013002167(A2) |
申请公布日期 |
2016.05.31 |
申请号 |
BR20131102167 |
申请日期 |
2011.08.23 |
申请人 |
ROCHE GLYCART AG |
发明人 |
CLAUDIO SUSTMANN;JUERGEN MICHAEL SCHANZER;PABLO UMANA;REBECCA CROASDALE;SILKE METZ;ULRICH BRINKMANN |
分类号 |
C07K16/00;C07K16/28;C07K16/32 |
主分类号 |
C07K16/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|